Diabetes Technology and Therapeutics

Diabetes technology has continually evolved over the years to improve quality of life and Ease of care for affected patients. Frequent blood glucose (BG) checks and multiple  daily insulin Injections have become standard of care in Type 1 diabetes (T1DM) management. Continuous glucose Monitors (CGM) allow patients to observe and discern trends in their glycemic control. These devices improve quality of life for parents and caregivers with preset alerts for hypoglycemia. Insulin Pumps have continued to improve and innovate since their emergence into the market. Hybrid Closed-loop systems have harnessed the data gathered with CGM use to aid in basal insulin dosing .And hypoglycemia  prevention. As technology continues to progress, patients will likely have to enter less and less information  into their pump system manually. In the future, we will likely see a system that requires no manual patient input and allows users to eat throughout the day without counting Carbohydrates or  entering in any blood sugars. As technology continues to advance, endocrinologists and diabetes providers need to stay current to better guide their patients in optimal use of emerging Management tools .

 

  • Type 1 Diabetes (T1DM) management
  • Continuous glucose Monitors (CGM)
  • Hypoglycemia
  • Closed-loop systems

Related Conference of Diabetes Technology and Therapeutics

September 09-10, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
September 25-26, 2024

5th World Summit on Diabetes Expo

Rome, Italy
October 14-15, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Diabetes Technology and Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in